Advertisement

Topics

Companies Related to "Eisai with Oncology Group Biomedicine Doubles Down Boston" [Most Relevant Company Matches] [Advanced Search Results] RSS

20:51 EDT 26th March 2019 | BioPortfolio

Here are the most relevant search results for "Eisai with Oncology Group Biomedicine Doubles Down Boston" found in our extensive corporate database of over 50,000 company records.

Showing "Eisai with Oncology Group Biomedicine Doubles Down Boston" Companies 1–25 of 4,900+

Extremely Relevant

Eisai Corporation of North America

Eisai Corporation of North America is a wholly-owned subsidiary of Eisai Co., Ltd. and supports the activities of its operating companies in North America. These operating companies include: Eisai Research Institute of Boston, Inc., a discovery operation with strong organic chemistry capabilities; Morphotek, Inc., a biopharmaceutical company specializing in the development of therapeutic monoclona...


Relevant

H3 Biomedicine Inc.

H3 Biomedicine is a biopharmaceutical company specializing in the discovery and development of oncology treatments. Using modern synthetic chemistry, chemical biology and human genetics, the company seeks to bring the next generation of cancer treatments to market with the goal of improving the lives of patients. H3 Biomedicine is based in Cambridge, Massa...

Eisai GmbH

Auf dem globalen Pharmamarkt zählt Eisai zu den führenden forschungs- orientierten Pharmaunternehmen. Mit innovativen Präparaten für Erkrankungen des Zentralen Nerven- systems sowie im Magen-Darm-Bereich hilft Eisai, die Lebensqualität von Patienten und deren Angehörigen zu verbessern. Eisai - als human health care Unternehmen weltweit aktiv und nah am Kunden.


Eisai Europe Ltd

Eisai is committed to developing and delivering highly beneficial new treatments to help improve the lives of people with epilepsy. The development of AEDs is a major strategic area for Eisai in the European market.

Eisai Europe Limited

Eisai is committed to making further contributions to addressing the diversified needs and improving quality of life of patients with epilepsy. Eisai has three currently marketed treatments in Europe, these are:

Eisai Inc.

Eisai Inc. was established in 1995 and is ranked among the top-20 U.S. pharmaceutical companies (based on retail sales). The company began marketing its first product in the United States in 1997 and has rapidly grown to become a fully integrated pharmaceutical business with fiscal year 2009 (year ended March 31, 2010) sales of approximately $3.9 billion. ...

Eisai Co., Ltd.

Eisai Co., Ltd. is a research-based human health care (hhc) company that discovers, develops and markets products throughout the world. Through a global network of research facilities, manufacturing sites and marketing subsidiaries, Eisai actively participates in all aspects of the worldwide healthcare system. Eisai employs approximately 11,000 employees w...

Eisai Inc

Eisai is a human health care (hhc) company seeking innovative solutions in disease prevention, cure and care for the health and well-being of people worldwide. Our company's hhc mission symbol is derived from the letters in Florence Nightingale's signature. Following the example set by this famed health care pioneer, who devoted her life to caring for others yet never lost sight of the importance ...

Boston Medical Group

For over a decade, Boston Medical Group’s network of independent physicians has provided men with solutions to treat sexual health issues such as erectile dysfunction and premature ejaculation. The physicians provide therapies and treatment programs that can help men regain their sexual health and function, including those who are unable to take syste...

OncLive

OncLive is the official website for Intellisphere’s Oncology Specialty Group, which publishes Oncology & Biotech News, OncologyLive, Oncology Nursing News, and Contemporary Oncology. The mission of OncLive and its family of publications is to provide oncology professionals with the resources and information they need to provide the best care for their...

Boston Biomedical, Inc.

Boston Biomedical, Inc. (Founder, Chairman, CEO and CMO: Chiang J. Li, M.D. FACP) was founded in November, 2006 and is a privately-held biotechnology company focused on the research and development of novel cancer therapeutics. Boston Biomedical has developed a world-leading product pipeline targeting cancer stem cells. Boston Biomedical’s innovation ...

Bial and Eisai

Founded in 1924, Bial is an international pharmaceutical group with products available in over 30 countries throughout four continents. BIAL is the largest Portuguese pharmaceutical company and is based in S. Mamede do Coronado, Portugal.

The Boston Globe

Boston Globe Media Partners, LLC provides news and information, entertainment, opinion and analysis through its multimedia properties. BGMP includes The Boston Globe, BostonGlobe.com, Boston.com, STAT and Globe Direct.

Children’s Oncology Group

The Children’s Oncology Group (COG), a National Cancer Institute supported clinical trials group, is the world’s largest organization devoted exclusively to childhood and adolescent cancer research. The COG unites more than 8,000 experts in childhood cancer at more than 200 leading children’s hospitals, universities, and cancer centers across ...

Premiere Oncology

Premiere Oncology is a center of excellence dedicated to treating cancer by providing comprehensive and holistic clinical care with attention to issues of survivorship and longevity. The group conducts meaningful oncology research with responsibility and integrity. The aim of the research program is to offer the hopes and benefits of cutting edge treatment to patients while generating data of th...

Boston’s Restaurant & Sports Bar

Headquartered in Dallas, Texas, Boston’s Restaurant & Sports Bar mirrors its sister company, Boston Pizza, the number one casual dining brand in Canada. Introduced in the U.S. in 1998, Boston’s Restaurant & Sports Bar is franchised by Boston Pizza Restaurants, L.P. Boston’s offers a contemporary, sit-down family dining atmosphere with a separate sp...

Boston Triathlon

The Columbia Threadneedle Investments Boston Triathlon is the only triathlon to take place in the City of Boston. The race draws athletes from all around the world, the country, the state and the city of Boston. Each summer, athletes descend on the South Boston waterfront for two days of racing. Now in its 10th year, the Columbia Threadneedle Investm...

Boston Equity Advisors

Boston Equity Advisors, LLC focuses its investment banking and advisory activities on therapeutic medical technology. Boston Equity Advisors provides strategic, financing and transactional expertise to help management navigate the financial markets and implement strategy for success. Boston Equity Advisors has a track record of providing counsel to innovat...

Cancer Center of Boston

The Cancer Center of Boston was established in September 1986 by Jacob J. Lokich, MD and Murray M. Bern, MD, formerly the chiefs of medical oncology and hematology, respectively, at the New England Deaconess Hospital. Their collaboration was based on the desire to develop a network of community based, freestanding facilities to diagnose and treat cancer and hematologic diseases with state-of-the-a...

Boston Millennia Partners

Boston Millennia Partners is a private equity investment partnership managing over $700 million in capital. Millennia invests in high-growth businesses in the healthcare and business services industries. Typical investments range from $3 to $15 million. The managers at Millennia have funded over 120 companies in the U.S. private equity market since 1980. S...

Xanttos Biomedicine GmbH

Xantos Biomedicine – the new dimension in genomics drug discoveryXantos is a biotechnology company applying a unique and novel technology (XantoScreen™) for the rapid identification of previously unknown, medically relevant genes in human cDNA-libraries. This is the basis to discover therapeutical targets for LMW drugs, genes, proteins and antibodies for direct therapeutic use, as well as diag...

Sample6 Technologies

Sample6 Technologies is the developer of the world’s first “enrichment-free” diagnostics platform powered by synthetic biology. It is backed by top tier venture capitalists including Flybridge Capital Partners, Chevron Tech Ventures, The Kraft Group, Founder Collective and Boston University. The company is based in Boston, MA. Learn more at www....

Prostate Oncology Specialists,Inc.

Prostate Oncology Specialists is a medical group exclusively devoted to caring for men with prostate cancer. We have vast experience diagnosing and treating prostate cancer because 100% of our time is focused on managing men with this disease. Our physicians are board certified in both medical oncology and internal medicine and have made significant contributions to the scientific advancement in t...

Boston Software Systems

Boston Software Systems is the leading standard for workflow automation and system integration software, enabling organizations to streamline complex business processes and improve productivity. Hundreds of organizations worldwide respond to regulatory and business initiatives by using Boston WorkStation technology to automate and improve processes through...

The Boston Home

Since 1881, The Boston Home has provided specialized clinical care and residential services for adults with progressive neurological diseases, primarily advanced MS. The Boston Home has extended its mission to serve individuals living with progressive neurological diseases in the community with services including B.Fit!, a day wellness and socialization pr...


More From BioPortfolio on "Eisai with Oncology Group Biomedicine Doubles Down Boston"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks